FTIOP
MLNT

Fiduciary Trust International of Pennsylvania’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Fiduciary Trust International of Pennsylvania’s Portfolio MLNT Stock Details MLNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-53,145
Closed -$1.05M – 350
2018
Q3 		$1.05M Hold
53,145
– – 0.04% 228
2018
Q2 		$1.69M Sell
53,145
-6,739
-11% -$243K 0.08% 187
2018
Q1 		$2.22M Buy
+59,884
New +$3.94M 0.1% 181

Other funds holding MLNT

OH
Oikos Holdings New York $422M AUM 13.79% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fiduciary Trust International of Pennsylvania's MLNT Position: Q4 2018 in Review

Fiduciary Trust International of Pennsylvania sold out of Melinta Therapeutics, Inc. Common Stock (MLNT) in Q4 2018, closing a stake of 53,145 shares — an estimated $1.05M sold.

Fiduciary Trust International of Pennsylvania first reported a position in MLNT in Q1 2018 and held it in 3 quarters. The position peaked at $2.22M in Q1 2018. 77 funds tracked by Wall St. Rank hold MLNT as of Q4 2018.

  • Fiduciary Trust International of Pennsylvania reported no remaining Melinta Therapeutics, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • Fiduciary Trust International of Pennsylvania sold 53,145 Melinta Therapeutics, Inc. Common Stock shares in Q4 2018, an estimated $1.05M.
  • Fiduciary Trust International of Pennsylvania first reported a position in Melinta Therapeutics, Inc. Common Stock in Q1 2018 and held it in 3 quarters.
  • Fiduciary Trust International of Pennsylvania's Melinta Therapeutics, Inc. Common Stock position peaked at $2.22M in Q1 2018.
  • 77 funds tracked by Wall St. Rank held Melinta Therapeutics, Inc. Common Stock as of Q4 2018.

Based on Fiduciary Trust International of Pennsylvania's 13F filing for Q4 2018, filed 14 Jan 2019.